Armeconombank’s normative capital to amount to AMD 23 billion after merger with BTA Bank

YEREVAN, March 21. /ARKA/. Armeconombank’s normative capital will amount to AMD 23 billion after merger with BTA Bank, the pres office of Armeconombank reported on Friday.
Its normative capital amounted to AMD 13.2 billion in 2015.

The memorandum on the merger of the banks was signed December 8 in Almaty (Kazakhstan) by top managers of BTA Bank Armenia and Armeconombank.

According to the press release, shareholders of both banks, at their extraordinary meetings were unanimous in approving the merger.

An appropriate contract will be submitted to the Central Bank of Armenia very soon.

The banks decided to merge to increase their capital in compliance with the central bank’s demand to commercial banks that obliges them to have no smaller than AMD 30-billion capital starting from January 1, 2017 instead of the 5 billion they must have now.

The central bank took this step to prompt commercial banks to merge and to improve their services, which will contribute to formation of healthy competition environment.

Armeconombank founded in 1991 is owned by EBRD -20%, Saribek Sukiasyan- 22.6%, Khachatur Sukiasyan – 19.5% and Robert Sukiasyan – 15.3%. The bank’s assets stood at 108.7 billion drams in 2015 (growth of 18.36%), its liabilities stood at 97.7 billion drams (up 20.92%), the capital was worth 11 billion drams (a decline of 0.34%). The bank closed the year with 368.7 million drams worth profit.

BTA Bank was founded in 1991. Its shareholders are BTA Bank (Kazakhstan) – 65.2%, ZRL Beteilingungs (Austria) -31.1% and PSC AMK-Invest LLC- 3.7%.
The bank’s assets totaled 14.9 billion in 2015 (9.21% decline) and its liabilities AMD 9.6 billion (11.2% decline). Its capital amounted to 5.3 billion (5.52%). The bank closed the year with losses amounting to AMD 187.3 million. ($1 – AMD 486.07). –0—-

spot_img

POPULAR

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

LATEST NEWS

spot_imgspot_imgspot_img